Drug Database · Food supplement

VENAMAX

Alpha-lipoic acid, Gamma-linolenic acid, Multivitamins, Selenium, Zinc

Food supplementKidney-marketedVitamin / mineral1 registration Kidney notes reviewed
Company: PHARMABEST INCORPORATED Last updated: Audience: Licensed health professionals
Registered with the Philippine FDA as a FOOD SUPPLEMENT — no approved therapeutic claims. Not a substitute for prescribed treatment.

Kidney notes

Venamax is registered as alpha-lipoic acid, gamma-linolenic acid, vitamins, selenium and zinc. The FDA record does not itemize the vitamins or their amounts.

Evidence

  • No clinical trials of Venamax itself were identified on PubMed.
  • Alpha-lipoic acid in kidney disease: in the PATH trial, 353 hemodialysis patients randomized to mixed tocopherols plus alpha-lipoic acid 600 mg/day or placebo for 6 months showed no effect on CRP, IL-6, oxidative-stress markers or erythropoietin response, with similar mortality and hospitalization (Himmelfarb 2014). A pilot RCT in CKD stages 3 to 4 also found no change in these markers (Ramos 2011).
  • No trials of gamma-linolenic acid for kidney outcomes were identified.

Cautions in kidney disease

  • Ask for the full vitamin and mineral content before use: the FDA record does not list which vitamins are included or their amounts.
  • Registered as a food supplement with no approved therapeutic claims; content and dose are not verified like a drug.

Bottom line

The best kidney trial of its main antioxidant ingredient (PATH) was negative. No basis to recommend it for kidney protection; check the vitamin content before a patient with advanced CKD takes it.

Sources

  1. Himmelfarb, J., Ikizler, T. A., Ellis, C., Wu, P., Shintani, A., Dalal, S., Kaplan, M., Chonchol, M., & Hakim, R. M. (2014). Provision of antioxidant therapy in hemodialysis (PATH): A randomized clinical trial. Journal of the American Society of Nephrology, 25(3), 623–633. https://doi.org/10.1681/ASN.2013050545
  2. Ramos, L. F., Kane, J., McMonagle, E., Le, P., Wu, P., Shintani, A., Ikizler, T. A., & Himmelfarb, J. (2011). Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease. Journal of Renal Nutrition, 21(3), 211–218. https://doi.org/10.1053/j.jrn.2010.08.003

Reviewed by William Gregory M. Rivero, MD, FPCP, DPSN on November 17, 2026. renalcarematters.com, reviewed

FDA Philippines registration

1 current food-supplement registration under the brand VENAMAX. Registration status changes; confirm a product's current status on the FDA verification portal using its FR number.

Verify on PH FDA portal

ALPHA-LIPOIC ACID, GAMMA-LINOLENIC ACID, VITAMINS, SELENIUM, ZINC COMPLEX FOOD SUPPLEMENT CAPSULE

Ingredients
  • Alpha-lipoic acid
  • Gamma-linolenic acid
  • Multivitamins
  • Selenium
  • Zinc
As registered: ALPHA-LIPOIC ACID, GAMMA-LINOLENIC ACID, VITAMINS, SELENIUM, ZINC COMPLEX
FR number
FR-4000015598736 · verify on the FDA portal
Registered as
Food supplement
Form
Capsule
Company
PHARMABEST INCORPORATED
Issued
January 16, 2026
Valid until
January 16, 2031
FDA risk class
High Risk
Application
Renewal

Related drug pages

Registered drug products that share an ingredient with this supplement. A drug registration carries approved indications and labeling; a food supplement does not, and its content and quality are not verified in the same way.

For health professionals. Data come from the FDA Philippines food-product registration database and may lag behind the official record. A food-supplement registration means the product may be sold as food; it is not an approval of safety or efficacy for any disease. Not a substitute for clinical judgment.